Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 14
COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India
Nandini Sharma, Saurav Basu, H. B. Lalwani, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1177-1177
Open Access | Times Cited: 12
Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies
Hui Wang, Shuxian Wang, Fang Ren, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 38-38
Open Access | Times Cited: 7
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina
Arnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Public Health and Economic Impact of Periodic COVID-19 Vaccination with BNT162b2 for Old Adults and High-Risk Patients in an Illustrative Prefecture of Japan: A Budget Impact Analysis
Mitsuhiro Nagano, Kosuke Tanabe, Kazumasa Kamei, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 10, pp. 2155-2177
Open Access | Times Cited: 1
Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization
Rima Moghnieh, Wajdi Haddad, Nayla Jbeily, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0306457-e0306457
Open Access | Times Cited: 1
Ethical concerns regarding heterologous COVID-19 vaccine administration
Somsri Wiwanitkit, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Salivary immune responses after COVID-19 vaccination
Kenny Nguyen, Boris Relja, Monica Epperson, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0307936-e0307936
Open Access
When clinicians and patients disagree on vaccination: what primary care clinicians can learn from COVID-19-vaccine-hesitant patients about communication, trust, and relationships in healthcare
Natalie Purcell, Hajra Usman, Nicole A. Woodruff, et al.
BMC Primary Care (2024) Vol. 25, Iss. 1
Open Access
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
COVID-19 Vaccination Effectively Reduces Pneumonia Severity as Assessed by Routine Chest Computed Tomography
Xiaohui Wang, Xiaotong Xie, Peina Zhang, et al.
Medical & Clinical Research (2023) Vol. 8, Iss. 11
Open Access
Page 1

Scroll to top